- Home
- RVMD vs MNDY Comparison
RVMD vs MNDY Comparison
Compare RVMD & MNDY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RVMD | MNDY |
|---|---|---|
| Founded | 2014 | 2012 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.5B | 7.4B |
| IPO Year | 2020 | 2021 |
Fundamental Metrics
Financial Performance| Metric | RVMD | MNDY |
|---|---|---|
| Price | $77.65 | $152.19 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 18 | 23 |
| Target Price | $77.11 | ★ $280.61 |
| AVG Volume (30 Days) | ★ 2.3M | 1.7M |
| Earning Date | 11-05-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 192.87 |
| EPS | N/A | ★ 1.23 |
| Revenue | N/A | ★ $1,166,095,000.00 |
| Revenue This Year | N/A | $28.81 |
| Revenue Next Year | $714.50 | $21.57 |
| P/E Ratio | ★ N/A | $124.41 |
| Revenue Growth | N/A | ★ 28.62 |
| 52 Week Low | $29.17 | $141.20 |
| 52 Week High | $79.07 | $342.64 |
Technical Indicators
Market Signals| Indicator | RVMD | MNDY |
|---|---|---|
| Relative Strength Index (RSI) | 79.18 | 40.09 |
| Support Level | $69.50 | $141.20 |
| Resistance Level | $78.17 | $148.97 |
| Average True Range (ATR) | 2.78 | 6.91 |
| MACD | 0.17 | 0.67 |
| Stochastic Oscillator | 90.88 | 47.87 |
Price Performance
Historical ComparisonAbout RVMD Revolution Medicines Inc.
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio and SOS1 and 4EBP1/mTORC1 programs.
About MNDY monday.com Ltd.
Monday.com is a work management platform allowing for increased collaboration and visibility across an organization. Delivered via a SaaS-based model, users can track progress across marketing and development initiatives, create and automate workflows, and manage IT approvals. Revenue is generated on a per-seat basis across several pricing tiers. As of fiscal 2024, the company had over 245,000 customers.